Trends in Asian health-tech: Investors take note of an innovation demanding population

Construction of Plant 3 inside the Samsung BioLogics headquarters and production facilities in Songdo district in Incheon, South Korea. Photographer: SeongJoon Cho/Bloomberg

Despite being home to more than half the world’s population and some of its most dynamic economies, Asia hasn’t traditionally been at the forefront of health-care innovation.

Continue reading this story with a subscription to DealStreetAsia.


Should your colleagues be reading this article too? Contact us for corporate subscriptions at